Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Supakarn Chamni & Wanchai De-Eknamkul. (2013) Recent progress and challenges in the discovery of new neuraminidase inhibitors. Expert Opinion on Therapeutic Patents 23:4, pages 409-423.
Read now
Read now
Articles from other publishers (16)
Pedro Laborda, Su-Yan Wang & Josef Voglmeir. (2016) Influenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological Activity. Molecules 21:11, pages 1513.
Crossref
Crossref
Mauro Pascolutti, Robin J. Thomson & Mark von Itzstein. 2016. Lead Generation. Lead Generation
651
686
.
Pintu Maity, Debasish Kundu & Brindaban C. Ranu. (2015)
Nickel-Copper-Catalyzed C(
sp
2
)N Cross-Coupling of Cyclic and Bridged Amides: An Access to Cyclic Enamides and Alkenyl Vince Lactams
. Advanced Synthesis & Catalysis 357:16-17, pages 3617-3626.
Crossref
Crossref
Cuauhtemoc Licona-Cassani, Alvaro R. Lara, Natividad Cabrera-Valladares, Adelfo Escalante, Georgina Hernández-Chávez, Alfredo Martinez, Francisco Bolívar & Guillermo Gosset. (2014) Inactivation of Pyruvate Kinase or the Phosphoenolpyruvate: Sugar Phosphotransferase System Increases Shikimic and Dehydroshikimic Acid Yields from Glucose in <b><i>Bacillus subtilis</i></b>. Microbial Physiology 24:1, pages 37-45.
Crossref
Crossref
Enguang Feng, Deju Ye, Jian Li, Dengyou Zhang, Jinfang Wang, Fei Zhao, Rolf Hilgenfeld, Mingyue Zheng, Hualiang Jiang & Hong Liu. (2012) Recent Advances in Neuraminidase Inhibitor Development as Anti-influenza Drugs. ChemMedChem 7:9, pages 1527-1536.
Crossref
Crossref
Rohit Singh & Robert Vince. (2012) 2-Azabicyclo[2.2.1]hept-5-en-3-one: Chemical Profile of a Versatile Synthetic Building Block and its Impact on the Development of Therapeutics. Chemical Reviews 112:8, pages 4642-4686.
Crossref
Crossref
Robin Thomson & Mark von Itzstein. 2012. Influenza Virus Sialidase - A Drug Discovery Target. Influenza Virus Sialidase - A Drug Discovery Target
77
104
.
Robin Thomson & Mark von Itzstein. 2011. Antiviral Drugs. Antiviral Drugs
383
400
.
Joanne Bronson, Murali Dhar, William Ewing & Nils Lonberg. 2011.
433
502
.
Rui Sheng Xiong, Qing Jie Zhao, Hang Hang Zhu, Zheng Liu, Ya Bing Wei & Jing Shan Shen. (2010) Synthesis of novel analogues of zanamivir as neuraminidase inhibitors. Chinese Chemical Letters 21:11, pages 1338-1341.
Crossref
Crossref
Javier Magano. (2009) Synthetic Approaches to the Neuraminidase Inhibitors Zanamivir (Relenza) and Oseltamivir Phosphate (Tamiflu) for the Treatment of Influenza. Chemical Reviews 109:9, pages 4398-4438.
Crossref
Crossref
Karen M. Bromfield, Henrik Gradén, Natalie Ljungdahl & Nina Kann. (2009) Synthetic applications of cationic iron and cobalt carbonyl complexes. Dalton Transactions:26, pages 5051.
Crossref
Crossref
Irene M. Lagoja & Erik De Clercq. (2006) Anti‐influenza virus agents: Synthesis and mode of action. Medicinal Research Reviews 28:1, pages 1-38.
Crossref
Crossref
Pierre Vogel & Maris Turks. (2007) Synthesis of Enantiomerically Enriched 2-Substituted Pyrrolidine Analogues of Norhygrine. Applicatin of the Hetero-Diels-Alder Addition of Sulfur Dioxide. HETEROCYCLES 72:1, pages 681.
Crossref
Crossref
Karen M. Bromfield, Henrik Gradén, Daniel P. Hagberg, Thomas Olsson & Nina Kann. (2007) An iron carbonyl approach to the influenza neuraminidase inhibitor oseltamivir. Chemical Communications:30, pages 3183.
Crossref
Crossref
Y. Sudhakara Babu, Pooran Chand & Pravin L. Kotian. 2006. Annual Reports in Medicinal Chemistry Volume 41. Annual Reports in Medicinal Chemistry Volume 41
287
297
.